Učitavanje...
The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
There is a global obesity epidemic that will continue to be a financial burden on healthcare systems around the world. Tackling obesity through diet and exercise should always be the first intervention, but this has not proved to be effective for a large number of patients. Pharmacotherapeutic optio...
Spremljeno u:
| Izdano u: | Ther Adv Chronic Dis |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772342/ https://ncbi.nlm.nih.gov/pubmed/26977279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622315620180 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|